British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	SURGIST EORTC 62063
Description	A phase 3 randomized study of surgery of residual disease in patients with metastatic GIST responding to imatinib
Reference	EORTC 62063 NCRN portfolio
Status / Sites	This study has been closed by EORTC owing to poor accrual
UK Chief Investigator Contact

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.